• Home
  • About
  • Contact us
  • Submit a News Releases
Tech News, Magazine & Review WordPress Theme 2017
  • Computing
  • Entertainment
  • Gaming
  • Mobile
  • Science
  • Security
  • Services
  • Software
  • Space
No Result
View All Result
  • Computing
  • Entertainment
  • Gaming
  • Mobile
  • Science
  • Security
  • Services
  • Software
  • Space
Technovanguard — Be at the forefront of technology news
No Result
View All Result

Aspirin slows down evolution of colorectal cancer cells

Justin Rowell by Justin Rowell
15.06.2022
Home Science

White aspirin pills sit on a black background.

Aspirin changes the way colorectal cancer cell populations evolve over time, making them less able to survive and proliferate, according to a new study.

Cancer starts when cells start dividing uncontrollably. Scientists have known that taking aspirin can help protect against the development of colorectal cancer—cancer that afflicts the colon or rectum—but the exact reason aspirin has this effect has been mostly a mystery.

“We asked what aspirin does to the Darwinian evolution of cells,” says Dominik Wodarz, professor of population health and disease prevention at the University of California, Irvine Program in Public Health and coauthor of the study in eLife.

“Cancer arises because cells evolve from a healthy state toward a pathogenic state where the cells divide without stopping. This happens when cells acquire a number of mutations, and these mutations are selected for. We found that aspirin affects these evolutionary processes and slows them down.”

The researchers found that aspirin alters the birth and death rates of colorectal cancer cells. Specifically, aspirin reduces the rate of tumor cell division and increases the rate of cell death.

The researchers, including lead author Natalia Komarova, professor of mathematics, started the work suspecting that aspirin may have a role to play in colorectal cancer‘s evolution, wherein the forces of natural selection—or the processes that determine which individuals in a population will survive and reproduce and which will not—govern whether or not cancer cells proliferate to the point where they become harmful or lethal.

“We thought that a slowed development of cancer due to aspirin must somehow arise from a slowed evolution of the cells toward malignancy,” says Komarova.

“What surprised us was that this mechanism could explain the level of protection seen in the human population quite well. In other words, the predicted magnitude was consistent with the protective effect seen in the human population, in epidemiological studies.”

A 2011 clinical trial revealed that people who took 600 milligrams of aspirin each day for two years had a 63% reduction in colorectal cancer occurrence in patients suffering from Lynch syndrome—an inherited condition that increases risk of developing certain types of cancer such as colorectal cancer. Many other studies corroborate those findings, but none until now has investigated a possible evolutionary explanation for why this happens.

“The novel part is really saying that aspirin changes the evolutionary outcome of carcinogenesis,” Wodarz says. “This work is an example showing that mathematical approaches can be very useful to understand complex phenomena in cancer biology; such insights would not be possible to obtain by experimentation alone. It requires the collaboration of empirical biological work and mathematics.”

Now, Komarova and the rest of the team want to find out whether aspirin has similar effects on cancers afflicting other organs in the body. “If not,” she asks, “in which organs is aspirin protective, and how could we explain these differences in the ability to protect against cancer?”

Source: UC Irvine

The post Aspirin slows down evolution of colorectal cancer cells appeared first on Technovanguard.


Next Post
Qualcomm’s new Snapdragon chip promises more power, less battery drain

Qualcomm's new Snapdragon chip promises more power, less battery drain

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended.

Imec Tenure-Track Holder Christian Haffner Awarded With ERC Starting Grant

Imec Tenure-Track Holder Christian Haffner Awarded With ERC Starting Grant

13.01.2022
Fallout TV show finally enters production – with some help from the MCU

Fallout TV show finally enters production – with some help from the MCU

07.01.2022

Trending.

LANL Publishes Guide to Quantum Computer Programming

LANL Publishes Guide to Quantum Computer Programming

15.06.2022
A Global Ocean Biogeochemical Observatory Becomes a Reality

A Global Ocean Biogeochemical Observatory Becomes a Reality

21.03.2022
ROCK5 Model B : une carte de dev sous RK3588

ROCK5 Model B : une carte de dev sous RK3588

13.01.2022
7 Essentials You Need to Complete Your Twitch Streaming Setup

7 Essentials You Need to Complete Your Twitch Streaming Setup

15.12.2021
XT-ZB1 DevKit : un module Zigbee et Bluetooth RISC-V à 2€

XT-ZB1 DevKit : un module Zigbee et Bluetooth RISC-V à 2€

27.12.2021
Technovanguard — Be at the forefront of technology news

Technovanguard - The latest news from the world of IT and modern technologies.

Categories

  • Computing
  • Entertainment
  • Gaming
  • Mobile
  • Science
  • Security
  • Services
  • Software
  • Space
  • Без рубрики

Tags

FEATUREDNEWS

Recent News

Tech giants form Metaverse Standards Forum to promote collaboration

Tech giants form Metaverse Standards Forum to promote collaboration

26.06.2022
The Umbrella Academy cast shares their favorite group scenes from season 3

The Umbrella Academy cast shares their favorite group scenes from season 3

26.06.2022
  • Home
  • About
  • Contact us
  • Submit a News Releases

© 2021 technovanguard.com.

No Result
View All Result
  • Computing
  • Entertainment
  • Gaming
  • Mobile
  • Science
  • Security
  • Services
  • Software
  • Space

© 2021 technovanguard.com.